BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17350468)

  • 1. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
    Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
    Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
    Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
    Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification.
    Stevens-Kroef M; Simons A; Gorissen H; Feuth T; Weghuis DO; Buijs A; Raymakers R; Geurts van Kessel A
    Cancer Genet Cytogenet; 2009 Dec; 195(2):97-104. PubMed ID: 19963108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 13q deletions in B-cell lymphoproliferative disorders: frequent association with translocation.
    Struski S; Helias C; Gervais C; Audhuy B; Zamfir A; Herbrecht R; Lessard M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):151-60. PubMed ID: 17452258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
    Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia.
    Gardiner A; Parker H; Glide S; Mould S; Robinson H; Tracy I; Stankovic T; Oscier D; Strefford J
    Leuk Res; 2012 Mar; 36(3):307-10. PubMed ID: 21955805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
    Stockero KJ; Fink SR; Smoley SA; Paternoster SF; Shanafelt TD; Call TG; Zent CS; Van Dyke DL; Kay NE; Dewald GW
    Cancer Genet Cytogenet; 2006 Apr; 166(2):152-6. PubMed ID: 16631472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia.
    Shackelford RE; Bhalodia AR; Cotelingam JD; Veillon DM; Lowery-Nordberg M
    Med Hypotheses; 2006; 66(3):509-12. PubMed ID: 16326028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
    Joshi AD; Dickinson JD; Hegde GV; Sanger WG; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
    Cancer Genet Cytogenet; 2007 Jan; 172(2):120-6. PubMed ID: 17213020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.
    Bentz M; Plesch A; Bullinger L; Stilgenbauer S; Ott G; Müller-Hermelink HK; Baudis M; Barth TF; Möller P; Lichter P; Döhner H
    Genes Chromosomes Cancer; 2000 Mar; 27(3):285-94. PubMed ID: 10679918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.
    Herold T; Jurinovic V; Mulaw M; Seiler T; Dufour A; Schneider S; Kakadia PM; Feuring-Buske M; Braess J; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Bohlander SK
    Genes Chromosomes Cancer; 2011 Jul; 50(7):546-58. PubMed ID: 21500311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
    Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
    Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique lethal blastoid transformation of B-cell chronic lymphocytic leukemia carrying ATM/11q deletion and trisomy 12.
    Lu Y; Huang Q
    Leuk Res; 2009 Aug; 33(8):e124-6. PubMed ID: 19269030
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of ATM deletions in 16 cases of splenic marginal-zone B-cell lymphoma (SMZBCL).
    Salido M; Astier L; Puigdecanet E; Espinet B; Florensa L; Solé F
    Haematologica; 2003 Nov; 88(11):ELT33. PubMed ID: 14607769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
    Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
    Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.